
E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & Podcasts
Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would like to have a read-along companion piece! Paper: Landing Page: Substack:
E133: Obinutuzumab for SLE (ALLEGORY) is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Good RCT this week, investigating the CD20 B cell inhibitor obinutuzumab for SLE. Sign up for my newsletter if you would lik...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Mar 19, 2026, 15:21 long, audio available.